PM2 EFFECTS OF PRIMARY PROPHYLACTIC G-CSF USE AND DURATION OF USE ON NEUTROPENIA HOSPITALIZATIONS FOR ELDERLY BREAST CANCER PATIENTS RECEIVING CHEMOTHERAPY

May 1, 2010, 00:00
10.1016/S1098-3015(10)72037-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)72037-4/fulltext
Title : PM2 EFFECTS OF PRIMARY PROPHYLACTIC G-CSF USE AND DURATION OF USE ON NEUTROPENIA HOSPITALIZATIONS FOR ELDERLY BREAST CANCER PATIENTS RECEIVING CHEMOTHERAPY
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72037-4&doi=10.1016/S1098-3015(10)72037-4
First page :
Section Title :
Open access? : No
Section Order : 117
Categories :
Tags :
Regions :
ViH Article Tags :